| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392311A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 03/03/2004 | EP1392309A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 03/03/2004 | EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 03/03/2004 | EP1392302A1 5-substituted-2-arylpyridines as crf1 modulators |
| 03/03/2004 | EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
| 03/03/2004 | EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases |
| 03/03/2004 | EP1392293A1 Method for treatment of tumors using nordihydroguaiaretic acid derivatives |
| 03/03/2004 | EP1392290A1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases |
| 03/03/2004 | EP1392289A2 Caspase inhibitors and uses thereof |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | EP1392272A1 Permeation enhancers |
| 03/03/2004 | EP1392268A2 Medicament containing a polyamine as an active substance |
| 03/03/2004 | EP1392264A1 Delivery of antiemetics through an inhalation route |
| 03/03/2004 | EP1392262A1 Delivery of drug esters through an inhalation route |
| 03/03/2004 | EP1392261A2 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 03/03/2004 | EP1392259A2 Delivery of erectile dysfunction drugs through an inhalation route |
| 03/03/2004 | EP1392257A1 Delivery of antihistamines through an inhalation route |
| 03/03/2004 | EP1392249A1 Nsaid formulation comprising a granular composition and an extra-granular composition |
| 03/03/2004 | EP1392241A2 System for osmotic delivery of pharmaceutically active agents |
| 03/03/2004 | EP1392230A1 Methods for treating or preventing diseases of the oral cavity |
| 03/03/2004 | EP1392116A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds |
| 03/03/2004 | EP1392115A1 Controlled release particles |
| 03/03/2004 | EP1284974B1 Triazolyl tropane derivatives as ccr5 modulators |
| 03/03/2004 | EP1162953B1 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances |
| 03/03/2004 | EP1149167B1 Viral vaccine |
| 03/03/2004 | EP1140020B1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 03/03/2004 | EP1131331B1 13-membered azalides and their use as antibiotic agents |
| 03/03/2004 | EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy |
| 03/03/2004 | EP1017692B1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/03/2004 | EP0929217B1 Sordarin derivatives |
| 03/03/2004 | EP0906313B1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 03/03/2004 | EP0859628B9 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 03/03/2004 | EP0839033B1 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral |
| 03/03/2004 | EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof |
| 03/03/2004 | CN1479872A Materials and methods to modulate ligand binding/enzymatic activity of alpha/beta proteins containing allosteric regulatory site |
| 03/03/2004 | CN1479749A Polysaccharide compound having immune stimulating activity |
| 03/03/2004 | CN1479739A Heterocyclic ether substituted imidazoquinolie compounds |
| 03/03/2004 | CN1479738A Thioether subsituted imidazoquinoline compound |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479654A Method for coating high-efficient ingredient on partial or complete in implants and on plants |
| 03/03/2004 | CN1479631A Reversible gelling system for ocular drug delivery |
| 03/03/2004 | CN1479624A Process for preparing aqueous extracts of plants and extracts so obtained |
| 03/03/2004 | CN1479619A Use of pyrazolo [4,3-d] pyrimidines |
| 03/03/2004 | CN1479616A Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers |
| 03/03/2004 | CN1478778A 抗真菌剂及其制备方法和中间体 Antifungal agent and its preparation method and intermediates |
| 03/03/2004 | CN1478774A Andrographolide trimaleate mono potassium salt and androgra pholide dimaleate tripotassium salt and their medicinal composition |
| 03/03/2004 | CN1478550A Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method |
| 03/03/2004 | CN1478545A Use of compound interferon in the treating of SARS disease |
| 03/03/2004 | CN1478540A Medicinal composition for treating diabetes and its complication and viral hepatitis and its preparation method |
| 03/03/2004 | CN1478517A Nosedrops made of natural plant for preventing and treating infectious virus |
| 03/03/2004 | CN1478516A Subspinose Chinese medicine preparation |
| 03/03/2004 | CN1478483A Beta-L-2'-dioxidition-nucleoside for treating hepatitis B |
| 03/03/2004 | CN1478476A Medicine for treating venereal wart and its preparation method |
| 03/03/2004 | CN1478474A Milk thistle silybum marianum self-emulsified micro-emulsion composition and its preparation process |
| 03/03/2004 | CN1478465A Biphenyl diester liquid medicinal composition containing fat |
| 03/03/2004 | CN1140535C Halo derivatives of 9-deoxo-9a-aza-9a-homery theromycin A. |
| 03/03/2004 | CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 03/03/2004 | CN1140276C Compound chlorhexidine cream and its preparing method |
| 03/03/2004 | CN1140182C Coca components, edible products having enhanced polyphenol content, methods of making same and medical us |
| 03/02/2004 | US6699989 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699899 Substituted acylhydroxamic acids and method of reducing TNFα levels |
| 03/02/2004 | US6699888 Antiinflammatory |
| 03/02/2004 | US6699887 Administering a therapeutically effective amount of a pyrrazole sulfide or ether compound to treat the human immunodeficiency virus infection |
| 03/02/2004 | US6699883 Antibiotics, bactericides, antitumor |
| 03/02/2004 | US6699878 Imidazonaphthyridines |
| 03/02/2004 | US6699871 Such as 7-((3r)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders |
| 03/02/2004 | US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine |
| 03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
| 03/02/2004 | US6699857 Tetrahydroquinolinyl 6-methyldihydrothiadiazinone derivatives and use thereof |
| 03/02/2004 | US6699856 Pyrazinones, compositions containing such compounds and methods of use |
| 03/02/2004 | US6699855 Pyrrolopyrazinones useful as serine protease inhibitors |
| 03/02/2004 | US6699854 2-substituted 4-heteroaryl- pyrimidines, inhibitors of cyclin-dependent kinases (cdks) |
| 03/02/2004 | US6699846 Such as ischemia and reperfusion injury, using specified glycolipids structurally related to monophosphoryl lipid a but with reduced proinflammatory and pyrogenic activity |
| 03/02/2004 | US6699836 Vancomycin analogs |
| 03/02/2004 | US6699835 Formulation of boronic acid compounds |
| 03/02/2004 | US6699656 Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
| 03/02/2004 | US6699510 Chlorite solution and an acid or acidulant formulation with dye to indicate where applied and rheology modifier to immobilize the composition on the teat surface and provides a barrier; mastitis treatment |
| 03/02/2004 | US6699492 Quinolone carboxylic acid compositions and related methods of treatment |
| 03/02/2004 | US6699481 Peptides for inhibition of herpes simplex virus entry |
| 03/02/2004 | US6699480 Vaccine compositions |
| 03/02/2004 | US6699479 Recombinant newcastle disease virus as an embryo vaccine |
| 03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |
| 03/02/2004 | CA2259449C Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction |
| 03/02/2004 | CA2221370C Composition for treating condyloma acuminata |
| 03/02/2004 | CA2198247C Ionene polymers containing biologically-active anions |
| 03/02/2004 | CA2158137C Therapeutic compositions containing a lithium compound and silica |
| 02/26/2004 | WO2004016794A1 Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
| 02/26/2004 | WO2004016653A2 Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase |
| 02/26/2004 | WO2004016650A1 Antimicrobial peptides, polypeptides comprising same, genes coding for said peptides, vectors, transformed organisms and compositions containing same |
| 02/26/2004 | WO2004016632A2 Lincomycin derivatives possessing antibacterial activity |
| 02/26/2004 | WO2004016619A1 Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors |
| 02/26/2004 | WO2004016613A2 Purine derivatives and their use as antiproliferative agents |
| 02/26/2004 | WO2004016612A2 New purine derivatives |
| 02/26/2004 | WO2004016588A1 Furanone derivatives and methods of making same |
| 02/26/2004 | WO2004016581A1 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 02/26/2004 | WO2004016551A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 02/26/2004 | WO2004016278A1 Methods for enhancing immune functions in neonatal mammals by administration of il-18 |